Derriford Hospital is a large teaching hospital in Plymouth, England. The hospital serves Plymouth and nearby areas of Devon and Cornwall. It also provides tertiary cardiothoracic surgery, neurosurgery and renal transplant surgery for the whole of the South West Peninsula.

There are 1,000 beds in Derriford Hospital.

During the past decade, Derriford Hospital conducted 190 clinical trials. In the 10-year time frame, 190 clinical trials started and 68 clinical trials were completed, i.e. on average, 35.8% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 43 clinical trials were completed. i.e. 75.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Derriford Hospital" #1 sponsor was "University Hospital Plymouth NHS Trust" with 36 trials, followed by "University College, London" with 19 trials sponsored, "Hoffmann-La Roche" with 16 trials sponsored, "Gilead Sciences" with 13 trials sponsored and "Janssen Research & Development, LLC" with 13 trials sponsored. Other sponsors include 243 different institutions and companies that sponsored additional 149 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Derriford Hospital" #1 collaborator was "Cancer Research UK" with 18 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 10 trials as a collaborator, "AstraZeneca" with 8 trials as a collaborator, "Eli Lilly and Company" with 7 trials as a collaborator and "University of Birmingham" with 6 trials as a collaborator. Other collaborators include 347 different institutions and companies that were collaborators in the rest 270 trials.

According to Clinical.Site data, the most researched conditions in "Derriford Hospital" are "Breast Cancer" (18 trials), "Lymphoma" (10 trials), "Colorectal Cancer" (8 trials), "Multiple Myeloma" (8 trials) and "COVID-19" (7 trials). Many other conditions were trialed in "Derriford Hospital" in a lesser frequency.

Most popular intervention types in "Derriford Hospital" are "Drug" (224 trials), "Other" (42 trials), "Procedure" (40 trials), "Biological" (34 trials) and "Device" (28 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (52 trials), "Rituximab" (11 trials), "Dexamethasone" (8 trials), "adjuvant therapy" (8 trials) and "quality-of-life assessment" (8 trials). Other intervention names were less common.

The vast majority of trials in "Derriford Hospital" are 302 trials for "All" genders, 30 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are 115 active trials in "Derriford Hospital". 1 are not yet recruiting, 59 are recruiting, 52 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 160 completed trials in Derriford Hospital, undefined suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in Derriford Hospital, 26 "Phase 1" clinical trials were conducted, 88 "Phase 2" clinical trials and 142 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 61 trials that are defined as “Not Applicable".

Derriford Hospital has several departments that took part in Clinical trials: "Derriford Hospital - Haematology" - 6 trials, "Derriford Hospital; Plymouth Oncology Centre" - 5 trials, "Derriford Hospital - Dept of Oncology Clinical Trials" - 2 trials, "Level 7, Urology Research Unit, Derriford Hospital" - 2 trials